Expertise in
9
conditions

Dr. Lorinda S. Chung

Stanford, CA
Expertise in
9
conditions
Specialties:Rheumatology
Offers Telehealth
Expertise in
9
conditions
OverviewInsuranceLocationsClinical Research

Overview

Lorinda Chung is a Rheumatologist in Stanford, California. Dr. Chung is highly rated in 9 conditions, according to our data. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Dermatomyositis, and Polymyositis.

Her clinical research consists of co-authoring 174 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in CA
Hospital Affiliations
Stanford Health Care
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA 94305
650-723-4000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma
Enrollment Status: Withdrawn
Publish Date: January 20, 2021
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

174 Total Publications

Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.
Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.
Journal: JAMA dermatology
Published: October 16, 2024
Similar Doctors
Vibeke Strand
Expertise in
12
conditions
Dr. Vibeke Strand
Rheumatology
Expertise in
12
conditions
Dr. Vibeke Strand
Rheumatology
306 Ramona Rd, 
Portola Valley, CA 
 (6.2 mi)
650-529-0150
Languages Spoken:
English

Vibeke Strand is a Rheumatologist in Portola Valley, California. Dr. Strand is highly rated in 12 conditions, according to our data. Her top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Tissue Biopsy.

Mark C. Genovese
Expertise in
8
conditions
Dr. Mark C. Genovese
Rheumatology
Expertise in
8
conditions
Dr. Mark C. Genovese
Rheumatology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
650-723-4000
Languages Spoken:
English
Offers Telehealth

Mark Genovese is a Rheumatologist in Stanford, California. Dr. Genovese is highly rated in 8 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis.

Expertise in
11
conditions
Dr. Lianne S. Gensler
Rheumatology
Expertise in
11
conditions
Dr. Lianne S. Gensler
Rheumatology

University Of California San Francisco

2330 Post St, 
San Francisco, CA 
 (28.3 mi)
415-476-4029
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lianne Gensler is a Rheumatologist in San Francisco, California. Dr. Gensler is highly rated in 11 conditions, according to our data. Her top areas of expertise are Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), Arthritis, and Rheumatoid Vasculitis.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile